B. Braun Medical debuts new Heparin Sodium Injections, offering the largest U.S. premixed line with enhanced barcodes and ...

B. Braun Medical Inc. (B. Braun), a leader in smart infusion therapy and pain management, announced today the launch of its new Heparin Sodium Injections into the U.S. market, expanding its portfolio ...

Baxter Recalls Peritoneal Dialysis Solution Baxter announced a voluntary recall of two lots of 0.9% Sodium Chloride Injection due to particulate matter found in the solution.

Norepinephrine bitartrate in 0.9% sodium chloride injection is indicated to raise blood pressure in adult patients with severe, acute hypotension, and it is one of the most commonly used ...

B. Braun Medical on March 2 issued a nationwide voluntary recall of its 250 milliliter injections of 0.9 percent sodium chloride. Advertisement. By: Erica Carbajal. Tuesday, March 8th, 2022.

The recall involves Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, packaged in single-dose infusion bags with an aluminum overwrap, 10 single-dose bags packed in a carton.

Heparin Sodium in Sodium Chloride Injection is contraindicated in patients with the following conditions: Uncontrollable active bleeding state, except when this is due to disseminated ...

Labetalol HCl injection, 100 mg/20 ml and 200 mg/40 ml vial had a market value of approximately $6 million in the 12 months ended March 2021, according to IQVIA.

Hospira has voluntarily recalled a single lot of 20mEq potassium chloride in 5% dextrose and 0.45% sodium chloride injection in 1000-mL flexible plastic containers.

Pantoprazole sodium 4 mg/mL in 0.9% sodium chloride injection was stable for at least 96 hours when stored at 3 5 or 23 25 °C. If further diluted, the final solution should be used within 96 hours.